![]() |
| (c) POSTECH |
Retina Global is a US based 501(c)(3) nonprofit that is focused on finding sustainable solutions to the ever-increasing issues with retinal diseases in underserved areas around the world. We also manage the Orange County Eye Project in Santa Ana, CA.
Friday, March 11, 2022
Smart LED Contact Lenses for Treating Diabetic Retinopathy
Tuesday, May 25, 2021
A new type of Gene Therapy demonstrates the potential to treat Blindness
![]() |
| (c) Veronique Juvin, Sciartwork |
Doctors have been able to use a form of gene therapy described as optogenetics for the first time to restore partial vision in a blind person. The research team genetically altered retinal ganglion cells to become light-sensitive in a man whose vision was destroyed by retinitis pigmentosa, a genetic disorder that breaks down cells that absorb and convert light into brain signals.
Thursday, March 11, 2021
Evidence of Retinal damage may indicate increased risk of Stroke and Dementia
![]() |
| (c) Progress in Retinal & Eye Research |
Wednesday, March 10, 2021
New Study links Alzheimer's disease to Age-related Macular Degeneration
![]() |
| (c) Cells [link below] |
Tuesday, February 23, 2021
New therapeutic approach to treating Age-related Macular Degeneration
Scientists have found that inhibition of Runt-related transcription factor 1 (RUNX1), which has been linked to retinal neovascularization and the development of abnormal blood vessels resulting in vision loss, presents a new therapeutic approach in the treatment of age-related macular degeneration (AMD). Their results are reported in The American Journal of Pathology.
Monday, February 15, 2021
Metformin may help in reducing the risk for Macular Degeneration
In a large case-control study using a national database of patients, metformin use was associated with reduced odds of developing age-related macular degeneration (AMD). This association was dose dependent, with the greatest benefit at low to moderate doses. When looking only at patients with diabetes, the authors note preservation of the dose-dependent decrease in the odds of patients developing AMD. Metformin does not appear to be protective in patients with diabetes and coexisting diabetic retinopathy. This study suggests that metformin may be useful as a preventive therapy for AMD and provides the basis for potential prospective clinical trials.
Saturday, October 24, 2020
A commonly used anti-VEGF may not be as effective in treating diabetic macular edema in black patients
Subscribe to:
Posts (Atom)






